PT  - JOURNAL ARTICLE
AU  - Kontopantelis, Evangelos
AU  - Mamas, Mamas A.
AU  - Webb, Roger T.
AU  - Castro-Avila, Ana
AU  - Rutter, Martin K.
AU  - Gale, Chris P.
AU  - Ashcroft, Darren M.
AU  - Pierce, Matthias
AU  - Abel, Kathryn M.
AU  - Price, Gareth
AU  - Faivre-Finn, Corinne
AU  - Van Spall, Harriette G.C.
AU  - Graham, Michelle M.
AU  - Morciano, Marcello
AU  - Martin, Glen P.
AU  - Sutton, Matt
AU  - Doran, Tim
TI  - Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation and region in England & Wales during 2020
AID  - 10.1101/2021.07.05.21259786
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.05.21259786
4099  - http://medrxiv.org/content/early/2021/07/07/2021.07.05.21259786.short
4100  - http://medrxiv.org/content/early/2021/07/07/2021.07.05.21259786.full
AB  - Background Deaths in the first year of the COVID-19 pandemic in England & Wales have been shown to be unevenly distributed socioeconomically and geographically. However, the full scale of inequalities may have been underestimated as most measures of excess mortality do not adequately account for varying age profiles of deaths between social groups. We measured years of life lost (YLL) attributable to the pandemic, directly or indirectly, comparing mortality across geographic and socioeconomic groups.Methods YLL for registered deaths in England & Wales, from 27th December 2014 until 25th December 2020, were calculated using 2019 single year sex-specific life tables for England & Wales. Panel time-series models were used to estimate expected YLL by sex, geographical region, and deprivation quintile between 7th March 2020 and 25th December 2020 by cause: direct deaths (COVID-19 and other respiratory diseases), cardiovascular disease & diabetes, cancer, and other indirect deaths - all other causes). Excess YLL during the pandemic period were calculated by subtracting observed from expected values. Additional analyses focused on excess deaths for region and deprivation strata, by age-group.Findings Between 7th March 2020 and 25th December 2020 there were an estimated 763,550 (95% CI: 696,826 to 830,273) excess YLL in England & Wales, equivalent to a 15% (95% CI: 14 to 16) increase in YLL compared to the equivalent time period in 2019. There was a strong deprivation gradient in all-cause excess YLL, with rates per 100,000 population ranging from (916; 95% CI: 820 to 1,012) for the least deprived quintile to (1,645; 95% CI: 1,472 to 1,819) for the most deprived. The differences in excess YLL between deprivation quintiles were greatest in younger age groups; for all-cause deaths, an average of 9.1 years per death (95% CI: 8.2 to 10.0) were lost in the least deprived quintile, compared to 10.8 (95% CI: 10.0 to 11.6) in the most deprived; for COVID-19 and other respiratory deaths, an average of 8.9 years per death (95% CI: 8.7 to 9.1) were lost in the least deprived quintile, compared to 11.2 (95% CI: 11.0 to 11.5) in the most deprived. There was marked variability in both all-cause and direct excess YLL by region, with the highest rates in both in the North West.Interpretation During 2020, the first calendar year of the COVID-19 pandemic, longstanding socioeconomic and geographical health inequalities in England & Wales were exacerbated, with the most deprived areas suffering the greatest losses in potential years of life lost.Funding NoneCompeting Interest StatementCG declares receiving support from Abbot and BMS towards this work, consulting fees from Amgen and AstraZeneca, honoraria from AstraZeneca, participation in Data Safety Monitoring Boards for several trials (TACTIC, DUAL-ACS, DANBLOCK, PROFID, RAPID NSTEMI, STEEER-AF), stock options with the European Heart Journal Quality of Care and Clinical Outcomes as Deputy Editor, and other financial interests with Wondr Medical. None of the other authors have anything relevant to declare.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are freely and publicly available from the Office of National Statistics website https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales